Wendy Meyr-Cherry
Family Medicine · St Charles, MONPI 1609961150
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 348 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$804
- Novo Nordisk$551
- AstraZeneca$435
- GSK$432
- Pfizer$364
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,989100%
- Education$120%
- Entertainment$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,177 |
| Lilly USA, LLC | 47 | $804 |
| Novo Nordisk | 34 | $551 |
| AstraZeneca | 26 | $435 |
| GSK | 28 | $432 |
| Pfizer | 25 | $364 |
| Amgen | 12 | $261 |
| Otsuka America Pharmaceutical, Inc. | 11 | $186 |
| Sanofi-aventis U.S. LLC | 9 | $166 |
| Merck | 11 | $160 |
| Teva Pharmaceuticals USA, Inc. | 8 | $145 |
| Johnson & Johnson | 9 | $144 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $138 |
| Boehringer Ingelheim | 9 | $131 |
| Novartis | 6 | $97 |
| Astellas Pharma US Inc | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Almatica Pharma LLC | 3 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Sanofi Pasteur Inc. | 3 | $72 |
| Medtronic | 2 | $42 |
| Nevro Corp. | 2 | $39 |
| Bayer | 2 | $38 |
| Genentech USA, Inc. | 2 | $34 |
| Impel Pharmaceuticals Inc. | 2 | $34 |
| Cranial Technologies, Inc | 2 | $32 |
| Abbott | 2 | $26 |
| Bardy Diagnostics, Inc. | 2 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Kaleo, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
| Optos, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$6,016 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 15 | $8,565 |
| Famotidine | 38 | $1,181 |
| Levothyroxine Sodium | 82 | $1,007 |
| Losartan Potassium | 81 | $840 |
| Atorvastatin Calcium | 96 | $819 |
| Pantoprazole Sodium | 40 | $786 |
| Amlodipine Besylate | 91 | $657 |
| Rosuvastatin Calcium | 36 | $541 |
| Lisinopril | 80 | $484 |
| Gabapentin | 26 | $466 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 25 | $453 |
| Metoprolol Succinate | 39 | $400 |
| Ezetimibe | 25 | $367 |
| Fenofibrate | 19 | $321 |
| Bupropion XlBupropion Hcl | 13 | $314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $160 | $8,56515 claims |
| Almatica Pharma LLCSertraline Hcl | $82 | $22619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in St Charles
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.